Bli medlem
Bli medlem

Du är här


BioStock: Respiratorius marches towards partnering deal

Things are heating up for the development company Respiratorius and its drug candidate VAL001. Step by step, a potential partnering deal is getting closer and expectations are in the air. These expectations can also be felt when the company publishes its Q2 report for the fiscal year 2022/2023. BioStock contacted CEO Johan Drott to find out more.

Read the full article at

This is a press release from BioStock - Connecting Innovation & Capital.

Författare Cision